Antiviral potential of nanoparticles for the treatment of Coronavirus infections

J Sarkar, S Das, S Aich, P Bhattacharyya… - Journal of Trace …, 2022 - Elsevier
Abstract Background On 31st December 2019 in Wuhan, China, severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2), was acknowledged. This virus spread quickly …

Multivalent nanomedicines to treat COVID-19: A slow train coming

TA Tabish, MR Hamblin - Nano Today, 2020 - Elsevier
The high transmission rate and serious consequences of the unprecedented COVID-19
pandemic make it challenging and urgent to identify viral pathogens and understand their …

Research and patents on coronavirus and COVID-19: A review

P Aranda, B Wicklein, C Ruiz-Garcia… - Recent Patents on …, 2020 - ingentaconnect.com
Background: COVID-19 pandemic is a global problem that requires the point of view of basic
sciences and medicine as well as social, economics and politics disciplines. Viral particles …

Nanostructures for drug delivery in respiratory diseases therapeutics: Revision of current trends and its comparative analysis

LÁ Ibarra-Sánchez, A Gámez-Méndez… - Journal of Drug Delivery …, 2022 - Elsevier
Respiratory diseases are leading causes of death and disability in developing and
developed countries. The burden of acute and chronic respiratory diseases has been rising …

[HTML][HTML] SARS-CoV-2 and its new variants: a comprehensive review on nanotechnological application insights into potential approaches

RK Raja, P Nguyen-Tri, G Balasubramani… - Applied …, 2023 - Springer
Abstract SARS-CoV-2 (COVID-19) spreads and develops quickly worldwide as a new global
crisis which has left deep socio-economic damage and massive human mortality. This virus …

Use of Nanomaterials for Diagnosis and Treatment: The Advancement of Next-Generation Antiviral Therapy

D Mittal, SA Ali - Microbial Drug Resistance, 2022 - liebertpub.com
Globally, viral illness propagation is the leading cause of morbidity and death, causing
wreaking havoc on socioeconomic development and health care systems. The rise of …

Characteristics of SARS-CoV2 that may be useful for nanoparticle pulmonary drug delivery

M Rabiei, S Kashanian, SS Samavati… - Journal of drug …, 2022 - Taylor & Francis
As a non-invasive method of local and systemic drug delivery, the administration of active
pharmaceutical ingredients (APIs) via the pulmonary route represents an ideal approach for …

Nanotechnology: A Potential Weapon to Fight against COVID‐19

AK Tiwari, A Mishra, G Pandey… - Particle & Particle …, 2022 - Wiley Online Library
The COVID‐19 infections have posed an unprecedented global health emergency, with
nearly three million deaths to date, and have caused substantial economic loss globally …

Architectured therapeutic and diagnostic nanoplatforms for combating SARS-CoV-2: role of inorganic, organic, and radioactive materials

A Pandey, AN Nikam, SP Mutalik… - ACS biomaterials …, 2020 - ACS Publications
Although extensive research is being done to combat SARS-CoV-2, we are yet far away
from a robust conclusion or strategy. With an increased amount of vaccine research …

Nanotechnology based solutions to combat zoonotic viruses with special attention to SARS, MERS, and COVID 19: Detection, protection and medication

SG Ramakrishnan, B Robert, A Salim, P Ananthan… - Microbial …, 2021 - Elsevier
Zoonotic viruses originate from birds or animal sources and responsible for disease
transmission from animals to people through zoonotic spill over and presents a significant …